Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Investments (2018 - 2021)

Historic Long-Term Investments for Silo Pharma (SILO) over the last 4 years, with Q3 2021 value amounting to $820126.0.

  • Silo Pharma's Long-Term Investments rose 863031.72% to $820126.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $820126.0, marking a year-over-year increase of 863031.72%. This contributed to the annual value of $200.0 for FY2020, which is 9787.1% down from last year.
  • As of Q3 2021, Silo Pharma's Long-Term Investments stood at $820126.0, which was up 863031.72% from $600000.0 recorded in Q2 2021.
  • Silo Pharma's Long-Term Investments' 5-year high stood at $820126.0 during Q3 2021, with a 5-year trough of $200.0 in Q4 2020.
  • Its 4-year average for Long-Term Investments is $187836.5, with a median of $12766.0 in 2019.
  • Its Long-Term Investments has fluctuated over the past 5 years, first tumbled by 9787.1% in 2020, then soared by 863031.72% in 2021.
  • Quarter analysis of 4 years shows Silo Pharma's Long-Term Investments stood at $12767.0 in 2018, then dropped by 26.42% to $9394.0 in 2019, then crashed by 97.87% to $200.0 in 2020, then soared by 409963.0% to $820126.0 in 2021.
  • Its Long-Term Investments stands at $820126.0 for Q3 2021, versus $600000.0 for Q2 2021 and $570000.0 for Q1 2021.